{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:24Z","timestamp":1777370844446,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Intramural Research Program of the National Human Genome Research Institute","award":["1ZIDHG200352-11"],"award-info":[{"award-number":["1ZIDHG200352-11"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>17q12 deletion syndrome encompasses a broad constellation of clinical phenotypes, including renal magnesium wasting, maturity-onset diabetes of the young (MODY), renal cysts, genitourinary malformations, and neuropsychiatric illness. Manifestations outside of the renal, endocrine, and nervous systems have not been well described.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report a 62-year-old male referred to the Undiagnosed Diseases Program (UDP) at the National Institutes of Health (NIH) who presented with persistent hypermagnesiuric hypomagnesemia and was found to have a 17q12 deletion. The patient exhibited several known manifestations of the syndrome, including severe hypomagnesemia, renal cysts, diabetes and cognitive deficits. Coronary CT revealed extensive coronary calcifications, with a coronary artery calcification score of 12,427. Vascular calcifications have not been previously reported in this condition. We describe several physiologic mechanisms and a review of literature to support the expansion of the 17q12 deletion syndrome to include vascular calcification.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Extensive coronary and vascular calcifications may be an extension of the 17q12 deletion phenotype, particularly if hypomagnesemia and hyperparathyroidism are prevalent. In patients with 17q12 deletions involving <jats:italic>HNF1B<\/jats:italic>, hyperparathyroidism and hypomagnesemia may contribute to significant cardiovascular risk.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-019-1533-5","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T14:03:23Z","timestamp":1568037803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Case report: extreme coronary calcifications and hypomagnesemia in a patient with a 17q12 deletion involving HNF1B"],"prefix":"10.1186","volume":"20","author":[{"given":"Howard J.","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Groden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie P.","family":"Hoenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan C.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos R.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willam","family":"Gahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7755-4042","authenticated-orcid":false,"given":"Danica","family":"Novacic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,9]]},"reference":[{"key":"1533_CR1","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1001\/jama.2015.12249","volume":"314","author":"WA Gahl","year":"2015","unstructured":"Gahl WA, Wise AL, Ashley EA. The undiagnosed diseases network of the National Institutes of Health: a National Extension. JAMA. 2015;314:1797\u20138.","journal-title":"JAMA"},{"key":"1533_CR2","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/0002-9149(94)90563-0","volume":"74","author":"AS Agatston","year":"1994","unstructured":"Agatston AS, Janowitz WR, Kaplan G, Gasso J, Hildner F, Viamonte M. Ultrafast computed tomography-detected coronary calcium reflects the angiographic extent of coronary arterial atherosclerosis. Am J Cardiol. 1994;74:1272\u20134.","journal-title":"Am J Cardiol"},{"key":"1533_CR3","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1086\/522591","volume":"81","author":"HC Mefford","year":"2007","unstructured":"Mefford HC, Clauin S, Sharp AJ, Moller RS, Ullmann R, Kapur R, et al. Recurrent reciprocal genomic rearrangements of 17q12 are associated with renal disease, diabetes, and epilepsy. Am J Hum Genet. 2007;81:1057\u201369.","journal-title":"Am J Hum Genet"},{"issue":"Suppl 1","key":"1533_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/dom.12715","volume":"18","author":"R El-Khairi","year":"2016","unstructured":"El-Khairi R, Vallier L. The role of hepatocyte nuclear factor 1\u03b2 in disease and development. Diabetes Obes Metab. 2016;18(Suppl 1):23\u201332.","journal-title":"Diabetes Obes Metab"},{"key":"1533_CR5","doi-asserted-by":"publisher","first-page":"720","DOI":"10.2337\/diab.46.4.720","volume":"46","author":"TM Frayling","year":"1997","unstructured":"Frayling TM, Bulamn MP, Ellard S, Appleton M, Dronsfield MJ, Mackie AD, et al. Mutations in the hepatocyte nuclear factor-1alpha gene are a common cause of maturity-onset diabetes of the young in the U.K. Diabetes. 1997;46:720\u20135.","journal-title":"Diabetes"},{"key":"1533_CR6","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1210\/jc.2012-3453","volume":"98","author":"S Ferr\u00e8","year":"2013","unstructured":"Ferr\u00e8 S, Bongers EMHF, Sonneveld R, Cornelissen EAM, van der Vlag J, van Boekel GAJ, et al. Early development of hyperparathyroidism due to loss of PTH transcriptional repression in patients with HNF1\u03b2 mutations? J Clin Endocrinol Metab. 2013;98:4089\u201396.","journal-title":"J Clin Endocrinol Metab"},{"key":"1533_CR7","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1111\/j.1523-1755.2005.00625.x","volume":"68","author":"P Igarashi","year":"2005","unstructured":"Igarashi P, Shao X, McNally BT, Hiesberger T. Roles of HNF-1beta in kidney development and congenital cystic diseases. Kidney Int. 2005;68:1944\u20137.","journal-title":"Kidney Int"},{"key":"1533_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.kint.2016.03.027","volume":"90","author":"RL Clissold","year":"2016","unstructured":"Clissold RL, Shaw-Smith C, Turnpenny P, Bunce B, Bockenhauer D, Kerecuk L, et al. Chromosome 17q12 microdeletions but not intragenic HNF1B mutations link developmental kidney disease and psychiatric disorder. Kidney Int. 2016;90:203\u201311.","journal-title":"Kidney Int"},{"key":"1533_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/archdischild-2014-306810","volume":"100","author":"F Laffargue","year":"2015","unstructured":"Laffargue F, Bourthoumieu S, Llanas B, Baudouin V, Lahoche A, Morin D, et al. Towards a new point of view on the phenotype of patients with a 17q12 microdeletion syndrome. Arch Dis Child. 2015;100:259\u201364.","journal-title":"Arch Dis Child"},{"key":"1533_CR10","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1681\/ASN.2008060633","volume":"20","author":"S Adalat","year":"2009","unstructured":"Adalat S, Woolf AS, Johnstone KA, Wirsing A, Harries LW, Long DA, et al. HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol JASN. 2009;20:1123\u201331.","journal-title":"J Am Soc Nephrol JASN"},{"key":"1533_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/HYPERTENSIONAHA.109.129171","volume":"54","author":"DH Ellison","year":"2009","unstructured":"Ellison DH, Loffing J. Thiazide effects and side effects: insights from molecular genetics. Hypertension. 2009;54:196\u2013202.","journal-title":"Hypertension"},{"key":"1533_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.bbrc.2010.11.108","volume":"404","author":"S Ferr\u00e8","year":"2011","unstructured":"Ferr\u00e8 S, Veenstra GJC, Bouwmeester R, Hoenderop JGJ, Bindels RJM. HNF-1B specifically regulates the transcription of the \u03b3a-subunit of the Na+\/K+-ATPase. Biochem Biophys Res Commun. 2011;404:284\u201390.","journal-title":"Biochem Biophys Res Commun"},{"key":"1533_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2369-7-10","volume":"7","author":"K Panichpisal","year":"2006","unstructured":"Panichpisal K, Angulo-Pernett F, Selhi S, Nugent KM. Gitelman-like syndrome after cisplatin therapy: a case report and literature review. BMC Nephrol. 2006;7:10.","journal-title":"BMC Nephrol"},{"key":"1533_CR14","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2215\/CJN.06810909","volume":"5","author":"L Heidet","year":"2010","unstructured":"Heidet L, Decramer S, Pawtowski A, Morini\u00e8re V, Bandin F, Knebelmann B, et al. Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases. Clin J Am Soc Nephrol CJASN. 2010;5:1079\u201390.","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"1533_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ypmed.2016.04.003","volume":"88","author":"HM Mamudu","year":"2016","unstructured":"Mamudu HM, Paul TK, Wang L, Veeranki SP, Panchal HB, Alamian A, et al. The effects of multiple coronary artery disease risk factors on subclinical atherosclerosis in a rural population in the United States. Prev Med. 2016;88:140\u20136.","journal-title":"Prev Med"},{"key":"1533_CR16","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1161\/01.CIR.96.5.1461","volume":"96","author":"A Schmermund","year":"1997","unstructured":"Schmermund A, Baumgart D, G\u00f6rge G, Seibel R, Gr\u00f6nemeyer D, Ge J, et al. Coronary artery calcium in acute coronary syndromes: a comparative study of electron-beam computed tomography, coronary angiography, and intracoronary ultrasound in survivors of acute myocardial infarction and unstable angina. Circulation. 1997;96:1461\u20139.","journal-title":"Circulation"},{"key":"1533_CR17","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1002\/jbmr.523","volume":"26","author":"DA Towler","year":"2011","unstructured":"Towler DA. Skeletal anabolism, PTH, & the bone-vascular Axis. J Bone Miner Res. 2011;26:2579\u201382.","journal-title":"J Bone Miner Res"},{"key":"1533_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00041552-200207000-00006","volume":"11","author":"T Vetter","year":"2002","unstructured":"Vetter T, Lohse MJ. Magnesium and the parathyroid. Curr Opin Nephrol Hypertens. 2002;11:403\u201310.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1533_CR19","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Dr\u00fceke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2006;69:1945\u201353.","journal-title":"Kidney Int"},{"key":"1533_CR20","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/sj.ki.5002241","volume":"71","author":"KR Neves","year":"2007","unstructured":"Neves KR, Graciolli FG, dos Reis LM, Graciolli RG, Neves CL, Magalh\u00e3es AO, et al. Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int. 2007;71:1262\u201370.","journal-title":"Kidney Int"},{"key":"1533_CR21","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1210\/jc.2003-030964","volume":"89","author":"E Schulz","year":"2004","unstructured":"Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab. 2004;89:4246\u201353.","journal-title":"J Clin Endocrinol Metab"},{"key":"1533_CR22","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00198-007-0539-1","volume":"19","author":"M Naves","year":"2008","unstructured":"Naves M, Rodr\u00edguez-Garc\u00eda M, D\u00edaz-L\u00f3pez JB, G\u00f3mez-Alonso C, Cannata-And\u00eda JB. Progression of vascular calcifications is associated with greater bone loss and increased bone fractures. Osteoporos Int. 2008;19:1161\u20136.","journal-title":"Osteoporos Int"},{"key":"1533_CR23","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1161\/ATVBAHA.117.309182","volume":"37","author":"AD ter Braake","year":"2017","unstructured":"ter Braake AD, Shanahan CM, de Baaij JHF. Magnesium counteracts vascular calcification: passive interference or active modulation? Arterioscler Thromb Vasc Biol. 2017;37:1431\u201345.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1533_CR24","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1038\/jid.2008.391","volume":"129","author":"J LaRusso","year":"2009","unstructured":"LaRusso J, Li Q, Jiang Q, Uitto J. Elevated dietary magnesium prevents connective tissue mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6(\u2212\/\u2212)). J Invest Dermatol. 2009;129:1388\u201394.","journal-title":"J Invest Dermatol"},{"key":"1533_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jcmg.2013.10.006","volume":"7","author":"A Hruby","year":"2014","unstructured":"Hruby A, O\u2019Donnell CJ, Jacques PF, Meigs JB, Hoffmann U, McKeown NM. Magnesium intake is inversely associated with coronary artery calcification: the Framingham heart study. JACC Cardiovasc Imaging. 2014;7:59\u201369.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1533_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12937-016-0143-3","volume":"15","author":"R Posadas-S\u00e1nchez","year":"2016","unstructured":"Posadas-S\u00e1nchez R, Posadas-Romero C, Cardoso-Salda\u00f1a G, Vargas-Alarc\u00f3n G, Villarreal-Molina MT, P\u00e9rez-Hern\u00e1ndez N, et al. Serum magnesium is inversely associated with coronary artery calcification in the genetics of atherosclerotic disease (GEA) study. Nutr J. 2016;15:22.","journal-title":"Nutr J"},{"key":"1533_CR27","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/0895-4356(94)00200-A","volume":"48","author":"J Ma","year":"1995","unstructured":"Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis risk in communities study. J Clin Epidemiol. 1995;48:927\u201340.","journal-title":"J Clin Epidemiol"},{"key":"1533_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12937-017-0247-4","volume":"16","author":"H Han","year":"2017","unstructured":"Han H, Fang X, Wei X, Liu Y, Jin Z, Chen Q, et al. Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies. Nutr J. 2017;16:26.","journal-title":"Nutr J."},{"issue":"Suppl 1","key":"1533_CR29","doi-asserted-by":"publisher","first-page":"i52","DOI":"10.1093\/ndtplus\/sfr167","volume":"5","author":"ZA Massy","year":"2012","unstructured":"Massy ZA, Dr\u00fceke TB. Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J. 2012;5(Suppl 1):i52\u201361.","journal-title":"Clin Kidney J"},{"key":"1533_CR30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1440-1797.2006.00660.x","volume":"11","author":"D Proudfoot","year":"2006","unstructured":"Proudfoot D, Shanahan CM. Molecular mechanisms mediating vascular calcification: role of matrix Gla protein. Nephrol Carlton Vic. 2006;11:455\u201361.","journal-title":"Nephrol Carlton Vic"},{"key":"1533_CR31","doi-asserted-by":"publisher","first-page":"14815","DOI":"10.1074\/jbc.M709938200","volume":"283","author":"A Heiss","year":"2008","unstructured":"Heiss A, Eckert T, Aretz A, Richtering W, van Dorp W, Sch\u00e4fer C, et al. Hierarchical role of fetuin-a and acidic serum proteins in the formation and stabilization of calcium phosphate particles. J Biol Chem. 2008;283:14815\u201325.","journal-title":"J Biol Chem"},{"key":"1533_CR32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1042\/CS20110506","volume":"122","author":"JAM Maier","year":"2012","unstructured":"Maier JAM. Endothelial cells and magnesium: implications in atherosclerosis. Clin Sci (Lond). 2012;122:397\u2013407.","journal-title":"Clin Sci (Lond)"},{"key":"1533_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/CRD.0000000000000003","volume":"22","author":"D Kolte","year":"2014","unstructured":"Kolte D, Vijayaraghavan K, Khera S, Sica DA, Frishman WH. Role of magnesium in cardiovascular diseases. Cardiol Rev. 2014;22:182\u201392.","journal-title":"Cardiol Rev"},{"key":"1533_CR34","first-page":"1754","volume":"15","author":"Z-Y Cheng","year":"2018","unstructured":"Cheng Z-Y, Ye T, Ling Q-Y, Wu T, Wu G-Y, Zong G-J. Parathyroid hormone promotes osteoblastic differentiation of endothelial cells via the extracellular signal-regulated protein kinase 1\/2 and nuclear factor-\u03baB signaling pathways. Exp Ther Med. 2018;15:1754\u201360.","journal-title":"Exp Ther Med"},{"key":"1533_CR35","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/sj.ki.5002532","volume":"72","author":"M Usatii","year":"2007","unstructured":"Usatii M, Rousseau L, Demers C, Petit J-L, Brossard J-H, Gascon-Barr\u00e9 M, et al. Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1,25(OH)2D synthesis. Kidney Int. 2007;72:1330\u20135.","journal-title":"Kidney Int"},{"key":"1533_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.bbaexp.2005.10.003","volume":"1731","author":"S Senkel","year":"2005","unstructured":"Senkel S, Lucas B, Klein-Hitpass L, Ryffel GU. Identification of target genes of the transcription factor HNF1beta and HNF1alpha in a human embryonic kidney cell line. Biochim Biophys Acta. 2005;1731:179\u201390.","journal-title":"Biochim Biophys Acta"},{"key":"1533_CR37","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.kint.2015.12.046","volume":"89","author":"NJ Paloian","year":"2016","unstructured":"Paloian NJ, Leaf EM, Giachelli CM. Osteopontin protects against high phosphate-induced nephrocalcinosis and vascular calcification. Kidney Int. 2016;89:1027\u201336.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1533-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1533-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1533-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T23:11:03Z","timestamp":1599520263000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1533-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,9]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1533"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1533-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,9]]},"assertion":[{"value":"3 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Protocol 15-HG-0130 was approved by the National Human Genome Research Institute (NHGRI) Institutional Review Board (IRB). The patient gave written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient provided written informed consent to this case\u2019s publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"353"}}